News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Business
IntegriChain Raises Series B
July 16, 2009
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
pehub.com -- IntegriChain Inc., a New York-based provider of data and analytics to the pharma industry, has raised an undisclosed amount of Series B funding. Milestone Venture Partners led the round, and was joined by Cross Atlantic Partners.
Twitter
LinkedIn
Facebook
Email
Print
Startups
MORE ON THIS TOPIC
Vaccines
Moderna partners with CEPI on Ebola vaccine efforts amid outbreak in Africa
June 1, 2026
·
2 min read
·
Gabrielle Masson
Metabolic disorders
Lilly maintains deal streak with $1.2B pact for Hanmi’s GLP-2 candidate
June 1, 2026
·
2 min read
·
Michael Gibney
China
Pfizer bets up to $10.5B in 12-candidate cancer collab with China’s Innovent
May 29, 2026
·
2 min read
·
Tristan Manalac
Obesity
Kailera walks path paved by Lilly in post-IPO ‘catalyst-rich period’
May 28, 2026
·
2 min read
·
Tristan Manalac
